Trademark Search in Canada

CELL FORGE

View On IC.GC.CA

REGISTERED

Last Applicant/ Owned by

Allogene Therapeutics, Inc.

210 E. Grand AvenueSouth San Francisco CA 94080

Serial Number

2146586 filed on 4^th Oct 2021

Registration Number

TMA1185557 registered on 14^th Jun 2023

Registration expiry Date

4^th Oct 2031

Correspondent Address

CLARK WILSON LLP

900 - 885 WEST GEORGIA STREETVANCOUVER

BRITISH COLUMBIA

V6C3H1

CELL FORGE

Trademark usage description

pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immuno Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T cell therapy.

Classification kind code

Mark Details

Serial Number

2146586

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 21^st Feb 2023	Approved
Submitted for opposition 27 on 21^st Feb 2023	Approval Notice Sent
Submitted for opposition 22 on 15^th Feb 2023	Search Recorded
Submitted for opposition 256 on 12^th Sept 2022	Notification of Possible Opposition Sent
Submitted for opposition 48 on 11^th May 2022	Agent Changed
Submitted for opposition 257 on 11^th Nov 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 10^th Nov 2021	Created
Submitted for opposition 31 on 10^th Nov 2021	Formalized
Submitted for opposition 228 on 4^th Oct 2021	International Registration
Submitted for opposition 30 on 4^th Oct 2021	Filed

CELL FORGE

Classification Information

Class [005]Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T cell therapy.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T cell therapy.